Online mindfulness program aims to ease chemo stress in breast cancer patients
NCT ID NCT06534957
First seen Jun 25, 2026 · Last updated Jun 30, 2026 · Updated 3 times
Summary
This study tests whether a 6-week online mindfulness program can lower stress, anxiety, and other side effects in women with breast cancer who are about to start chemotherapy. Two hundred participants will be randomly assigned to either the online mindfulness sessions or no extra support. The goal is to see if a simple, home-based program can make treatment easier to handle.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- online mindfulness-based stress reduction (MBSR)
- What this could lead to
- If it works, this could offer a free, home-based way to help breast cancer patients feel less stressed and manage treatment side effects.
- What could go wrong
- This is a small, early-stage study with no blinding, so results may be influenced by participants' expectations. The intervention is only 6 weeks long, and benefits may not last.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
128 people
The number who actually took part.
- Started
-
Sep 2025
- Finished
-
Jun 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Female sex * Age ≥18 years * Diagnosis of non-metastatic breast cancer * Treatment with neoadjuvant or adjuvant chemotherapy or plan to start chemotherapy in \<4 weeks * Internet access at home or in their mobile phone * Availability to participate in the online MBI for 6 weeks * Availability to answer the study surveys * Provision of signed informed consent Exclusion Criteria: * Disease recurrence * Current meditation or mindfulness practice * Inability to read or write
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Zambrano Hellion
San Pedro Garza García, Nuevo León, 66278, Mexico
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common steroid shield breast cancer patients from a dangerous drug side effect?
- Tiny magnetic seeds could guide surgeons to the right lymph node
- New PET tracer aims to light up hidden cancer targets
- Gut bacteria supplement tested against chemo hair loss
- Can a mindfulness program boost Self-Compassion in breast cancer survivors?
- Can a Decades-Old Anti-Inflammatory drug quiet the joint pain that drives women off breast cancer therapy?